India and the United States are at an advanced stage in India-US Bilateral Trade Agreement (BTA), according to a confirmation made by Commerce and Industry Minister Piyush Goyal on Monday. This announcement highlights a significant push in diplomatic and economic efforts to remove trade barriers and establish a more predictable commercial environment between the two […]
India and New Zealand have successfully concluded a Free Trade Agreement (FTA), an achievement notable for being one of India’s quickest trade deals with a developed economy. This agreement is set to significantly enhance bilateral trade, boost investment, and strengthen people-to-people connections between the two nations. Key Trade Liberalization The agreement features substantial market access
India–New Zealand FTA Concluded: 95% of Tariffs to be Slashed Read More »
Indian Markets | IPO Watch ICICI Prudential Asset Management Company(ASM) delivered a strong debut on Dalal Street, emerging as the most valuable company within India’s capital market ecosystem after its stock surged sharply on the first day of listing. The shares jumped over 23 percent during intraday trade, touching a high of ₹2,663, before closing
ICICI Prudential AMC Emerges as the Most Valuable Capital Market Stock After 19% surge Read More »
Indian IT major Infosys Ltd’s American Depository Receipt (ADR) witnessed an exceptional spike in US trading on December 19, driven purely by a technical short squeeze, not by any fundamental trigger. The Infosys ADR surged as much as 40% intraday, touching a 52-week high, before volatility controls led to a temporary trading halt. At around
Infosys ADR Surge 40% After Rare Short Squeeze, Trading Halt Triggered in US Read More »
Pharmaceutical stocks surged on December 19 after the US Senate passed the Biosecure Act as part of the fiscal 2026 National Defense Authorization Act (NDAA), a move seen as structurally positive for Indian drug makers. The rally pushed the Nifty Pharma index up 0.65% to 22,704, after hitting an intraday high of over 1.35%. Investor
Pharma Stocks surge After US Senate Passes Biosecure Act; Nifty Pharma Gains Read More »
